EB-101

FDA puts the brakes on a rare disease biotech’s PhIII as regulators wait for an update — shares crumble
Endpoints
Mon, 09/23/19 - 10:41 am
Abeona Therapeutics
clinical trials
EB-101
recessive dystrophic epidermolysis bullosa
FDA
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
3 Biotech Stocks That Skyrocketed This Past Week
Motley Fool
Mon, 09/4/17 - 10:07 am
Abeona Therapeutics
EB-101
Sangamo BioSciences
SB-525
Juno Therapeutics
CAR-T